[ad_1] Darren McCollester/Getty Images A lawsuit alleges that Purdue Pharma execs knew about OxyContin’s addictive potential ‘long before’ they publicly admitted it. Top executives at Purdue Pharma, the company that makes OxyContin, …
Read More »Poursuite de Purdue Pharma: la famille Sackler poursuivie pour avoir commis des opioïdes
[ad_1] La famille Sackler, le riche clan derrière le fabricant d'OxyContin, Purdue Pharma, est maintenant poursuivie en justice pour le compte d'analgésiques opioïdes dans un comté de New York – et des …
Read More »Top News in Pharma News on October 19, 2018 (2 of 4)
[ad_1] For the first time, scientists have trained dogs to remain motionless in a brain scan to determine how the canine brain distinguishes old words from new ones. When science begins to …
Read More »Inovio Pharma (INO) says its Ebola vaccine provides 100% protection
[ad_1] Receive instant alerts when news about your actions unfolds. Claim your free 2 week trial at StreetInsider Premium right here. Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Ebola vaccine …
Read More »Live Market: Sensex and Nifty exchange after a flat opening; IT, pharma index up 1-2%
[ad_1] Market Update The benchmarks for the shares are trading down, with the Nifty yielding 10,450 marks. The Sensex is down about one-fifth of one percent. The Sensex is down 71.57 points …
Read More »DEA plans Epidiolex, allowing GW Pharma to start selling the drug
[ad_1] The Drug Enforcement Administration reprogrammed Epidiolex, paving the way for GW Pharmaceuticals to sell the first FDA-approved drug derived from cannabis, but not allowing reclassification of all cannabidiol-based products.
Read More »A gallery owner behind a heroin spoon sculpture placed outside Purdue Pharma gets an accelerated rehabilitation
[ad_1] Fernando Luis Alvarez, owner of the Stamford Art Gallery, benefited on Monday from an accelerated rehabilitation for accusing Purdue Pharma, the famous maker of Oxycontin, of having laid a spoon sculpture …
Read More »Pharma CEO buys 400% price of drugs, citing "moral imperative to earn money"
[ad_1] CEO of a small pharmaceutical company defended the price of an essential antibiotic of more than 400% and Financial Times that he thinks that "it is a moral requirement to make …
Read More »Pharma Exec: price rise of 400% is a "moral requirement"
[ad_1] Nirmal Mulye, founder and president of Nostrum Laboratories in Missouri, said the price increase of a $ 474.75 to $ 2,932 nitrofurantoin antibiotic bottle constitutes a "moral requirement" in an interview …
Read More »Colorado pursues Purdue Pharma for its role in the opioid crisis
[ad_1] The number of lawsuits filed by states against Purdue Pharma LP, the maker of the pain medication Oxycontin, continues to grow as the Colorado Attorney General became the latest to sue …
Read More »